Guruprasad Ananda

2.9k total citations · 1 hit paper
30 papers, 1.8k citations indexed

About

Guruprasad Ananda is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Guruprasad Ananda has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Guruprasad Ananda's work include Cancer Genomics and Diagnostics (12 papers), Genomics and Phylogenetic Studies (9 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Guruprasad Ananda is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Genomics and Phylogenetic Studies (9 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Guruprasad Ananda collaborates with scholars based in United States, France and South Korea. Guruprasad Ananda's co-authors include Anton Nekrutenko, James Taylor, Daniel Blankenberg, Gregory Von Kuster, Ross Lazarus, Mary Mangan, Kateryna D. Makova, Francesca Chiaromonte, Kristin A. Eckert and Suzanne E. Hile and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Genes & Development.

In The Last Decade

Guruprasad Ananda

29 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Galaxy: A Web‐Based Genome Analysis Tool for Experimentalists

2010 1.1k citations Guruprasad Ananda, Anton Nekrutenko et al. profile →

Peers

Countries citing papers authored by Guruprasad Ananda

Since Specialization

Citations

This map shows the geographic impact of Guruprasad Ananda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guruprasad Ananda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guruprasad Ananda more than expected).

Fields of papers citing papers by Guruprasad Ananda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guruprasad Ananda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guruprasad Ananda. The network helps show where Guruprasad Ananda may publish in the future.

Co-authorship network of co-authors of Guruprasad Ananda

This figure shows the co-authorship network connecting the top 25 collaborators of Guruprasad Ananda. A scholar is included among the top collaborators of Guruprasad Ananda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guruprasad Ananda. Guruprasad Ananda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A panel‐based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration‐resistant prostate cancer 2024 ·The Prostate ·(unknown), Alok K. Tewari, D. Gulhan, Ziad Bakouny, Guruprasad Ananda, (unknown), (unknown), (unknown), Rebecca Silver, Toni K. Choueiri, Mary‐Ellen Taplin, Peter J. Park, Jacob E. Berchuck	0
2	RNA-Seq for the detection of gene fusions in solid tumors: development and validation of the JAX FusionSeq™ 2.0 assay 2022 ·Journal of Molecular Medicine ·(unknown), Harshpreet Chandok, Qian Nie, (unknown), (unknown), Kevin Kelly, Guruprasad Ananda, (unknown), Honey V. Reddi	7
3	Transcriptomic stratification of late-onset Alzheimer's cases reveals novel genetic modifiers of disease pathology 2020 ·PLoS Genetics ·(unknown), Christoph Preuß, Annat Haber, Guruprasad Ananda, Shubhabrata Mukherjee, (unknown), (unknown), Benjamin A. Logsdon, Paul K. Crane, Gregory W. Carter	31
4	HELLS and PRDM9 form a pioneer complex to open chromatin at meiotic recombination hot spots 2020 ·Genes & Development ·(unknown), (unknown), Guruprasad Ananda, (unknown), Hui Tian, Kenneth Paigen, Gregory W. Carter, Christopher L. Baker	47
5	Astrocyte Support for Oligodendrocyte Differentiation can be Conveyed via Extracellular Vesicles but Diminishes with Age 2020 ·Scientific Reports ·Cory M. Willis, Alexandra M. Nicaise, Ernesto R. Bongarzone, Maria I. Givogri, (unknown), (unknown), Evan R. Jellison, (unknown), (unknown), Guruprasad Ananda, Anthony T. Vella, Stephen J. Crocker	63
6	The Genome of C57BL/6J “Eve”, the Mother of the Laboratory Mouse Genome Reference Strain 2019 ·G3 Genes Genomes Genetics ·Vishal Sarsani, Narayanan Raghupathy, Ian T. Fiddes, Joel Armstrong, Françoise Thibaud‐Nissen, (unknown), Mohan Bolisetty, Kerstin Howe, (unknown), Xiaoan Ruan, Lucy B. Rowe, Mary Barter, Guruprasad Ananda, Benedict Paten, George M. Weinstock, Gary A. Churchill, Michael V. Wiles, Valérie Schneider, Anuj Srivastava, Laura G. Reinholdt	40
7	Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines 2019 ·BMC Medical Genomics ·Xing Yi Woo, Anuj Srivastava, Joel H. Graber, Vinod Kumar Yadav, Vishal Sarsani, (unknown), Glen Beane, Stephen C. Grubb, Guruprasad Ananda, Rangjiao Liu, Grace A. Stafford, Jeffrey H. Chuang, Susan Airhart, R. Krishna Murthy Karuturi, Joshy George, Carol J. Bult	21
8	Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ Assay 2019 ·Molecular Diagnosis & Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Qian Nie, Guruprasad Ananda, Harshpreet Chandok, Kevin Kelly, (unknown), Honey V. Reddi	1
9	Technical and Regulatory Considerations for Taking Liquid Biopsy to the Clinic: Validation of the JAX PlasmaMonitor^TM Assay 2019 ·Biomarker Insights ·(unknown), (unknown), Kevin Kelly, (unknown), (unknown), Guruprasad Ananda, Harshpreet Chandok, (unknown), (unknown), Honey V. Reddi	19
10	High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts 2018 ·Scientific Reports ·Hyunsoo Kim, Pooja Kumar, Francesca Menghi, Javad Noorbakhsh, Eliza Cerveira, (unknown), Qihui Zhu, Guruprasad Ananda, Joshy George, (unknown), Susan M. Mockus, Chengsheng Zhang, Yan Yang, James Keck, R. Krishna Murthy Karuturi, Carol J. Bult, Charles Lee, Edison T. Liu, Jeffrey H. Chuang	9
11	Tissue-Specific Trans Regulation of the Mouse Epigenome 2018 ·Genetics ·Christopher L. Baker, Michael Walker, Seda Arat, Guruprasad Ananda, (unknown), Natalie R. Powers, Hui Tian, (unknown), Bo Ji, Dylan M. Rausch, Kwangbom Choi, Petko M. Petkov, Gregory W. Carter, Kenneth Paigen	10
12	P4‐031: NOVEL MODELS OF LATE‐ONSET ALZHEIMER'S DISEASE BASED ON GWAS 2018 ·Alzheimer s & Dementia ·Michael Sasner, Harriet M. Williams, Adrian L. Oblak, Rita O’Rourke, Christoph Preuß, Andrew J. Saykin, Stacey J. Sukoff Rizzo, Guruprasad Ananda, Vivek M. Philip, Gregory W. Carter, Bruce T. Lamb, Gareth R. Howell	1
13	Somatic gene mutation analysis of triple negative breast cancers 2016 ·The Breast ·(unknown), Susan M. Mockus, Guruprasad Ananda, (unknown), Wendy A. Wells, Gregory J. Tsongalis, Jonathan D. Marotti	20
14	Molecular Genetic Analysis of Ovarian Brenner Tumors and Associated Mucinous Epithelial Neoplasms 2016 ·American Journal Of Pathology ·Laura J. Tafe, Kristen E. Muller, Guruprasad Ananda, Talia Mitchell, (unknown), Sara E. Patterson, Gregory J. Tsongalis, Susan M. Mockus	28
15	Accurate typing of short tandem repeats from genome-wide sequencing data and its applications 2015 ·Genome Research ·Arkarachai Fungtammasan, Guruprasad Ananda, Suzanne E. Hile, Marcia Shu‐Wei Su, Chen Sun, Robert S. Harris, Paul Medvedev, Kristin A. Eckert, Kateryna D. Makova	65
16	Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors 2015 ·Experimental and Molecular Pathology ·Guruprasad Ananda, Susan M. Mockus, (unknown), (unknown), (unknown), Talia Mitchell, Grace A. Stafford, Vivek M. Philip, Timothy M. Stearns, Anuj Srivastava, Mary Barter, Lucy B. Rowe, Joan Malcolm, Carol J. Bult, R. Krishna Murthy Karuturi, (unknown), Douglas Hinerfeld	25
17	Microsatellite Interruptions Stabilize Primate Genomes and Exist as Population-Specific Single Nucleotide Polymorphisms within Individual Human Genomes 2014 ·PLoS Genetics ·Guruprasad Ananda, Suzanne E. Hile, (unknown), Yanli Wang, Yogeshwar Kelkar, Kateryna D. Makova, Kristin A. Eckert	23
18	Distinct Mutational Behaviors Differentiate Short Tandem Repeats from Microsatellites in the Human Genome 2012 ·Genome Biology and Evolution ·Guruprasad Ananda, Erin Walsh, Kimberly D. Jacob, Maria M. Krasilnikova, Kristin A. Eckert, Francesca Chiaromonte, Kateryna D. Makova	45
19	A genome-wide view of mutation rate co-variation using multivariate analyses 2011 ·Genome biology ·Guruprasad Ananda, Francesca Chiaromonte, Kateryna D. Makova	28
20	Windshield splatter analysis with the Galaxy metagenomic pipeline 2009 ·Genome Research ·Sergei L. Kosakovsky Pond, Samir Wadhawan, Francesca Chiaromonte, Guruprasad Ananda, Wen-Yu Chung, James Taylor, Anton Nekrutenko, (unknown)	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact